Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Guide to In Silico Drug Design
Yiqun Chang, Bryson A. Hawkins, Jonathan J. Du, et al.
Pharmaceutics (2022) Vol. 15, Iss. 1, pp. 49-49
Open Access | Times Cited: 105

Showing 1-25 of 105 citing articles:

Anticonvulsant effect of (±) citronellal possibly through the GABAergic and voltage-gated sodium channel receptor interaction pathways: In vivo and in silico studies
Raihan Chowdhury, Md. Shimul Bhuia, Md. Sakib Al Hasan, et al.
Neurochemistry International (2024) Vol. 175, pp. 105704-105704
Closed Access | Times Cited: 23
The importance of in-silico studies in drug discovery
Miah Roney, Mohd Fadhlizil Fasihi Mohd Aluwi
Intelligent Pharmacy (2024) Vol. 2, Iss. 4, pp. 578-579
Open Access | Times Cited: 10
Possible hemoglobin enhancing effect of phytol in methotrexate-induced folate deficient Swiss albino mice: In vivo and in silico studies
Muhammad Torequl Islam, Raihan Chowdhury, Md. Sakib Al Hasan, et al.
Pharmaceutical Science Advances (2024) Vol. 2, pp. 100043-100043
Open Access | Times Cited: 9
Practical Three-Component Regioselective Synthesis of Drug-Like 3-Aryl(or heteroaryl)-5,6-dihydrobenzo[h]cinnolines as Potential Non-Covalent Multi-Targeting Inhibitors To Combat Neurodegenerative Diseases
Hossein Mousavi, Mehdi Rimaz, Behzad Zeynizadeh
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 9, pp. 1828-1881
Closed Access | Times Cited: 6
Repurposing FDA-Approved Drugs for Eumycetoma Treatment: Homology Modeling and Computational Screening of CYP51 Inhibitors
Magdi Awadalla Mohamed, Mohamed Awadalla, Malik Suliman Mohamed, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 315-315
Open Access
Investigation of alpha-glucosidase inhibition activity of Artabotrys sumatranus leaf extract using metabolomics, machine learning and molecular docking analysis
Dela Rosa, Berna Elya, Muhammad Hanafi, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0313592-e0313592
Open Access
Structure-guided identification of potential MTH1 inhibitors from natural compounds: toward therapeutic targeting of oxidative DNA damage in cancer
Aaliya Taiyab, Taj Mohammad, Md Nayab Sulaimani, et al.
Chemical Papers (2025)
Closed Access
Improving the antimicrobial potential of the peptide CIDEM-501 through acylation: A computational approach
Daniel Alpízar-Pedraza, Adrian Romero-Rivero, Rolando Perdomo-Morales, et al.
Biochimica et Biophysica Acta (BBA) - Biomembranes (2025) Vol. 1867, Iss. 3, pp. 184407-184407
Closed Access
Computer-guided identification of novel inhibitors of apoptosis-signaling kinase 1 from Spondia mombim bioactive compounds against colorectal cancer
Olusola Olalekan Elekofehinti, Hannah Oluwaseun Popoola, Adedotun Olayemi Oluwatuyi, et al.
Egyptian Journal of Medical Human Genetics (2025) Vol. 26, Iss. 1
Open Access
Design, and Evaluation of In-Silico Anti-cancer Activity of Novel Gefitinib Analogues Against 21 Target Proteins
Supriti Khan Ushna, Ananta Kumar Das
Deleted Journal (2025), pp. 100030-100030
Closed Access
In-vitro and in-silico evaluation of antihyperglycemic, antioxidant, anti-inflammatory activities of selected (2Z)-2-((E)(2'hydroxy)-4(benzylideneamino)phenyl)-3-(1-methyl-1H-imidazol-2-yl)acrylonitrile derivatives
Nagarjuna Prakash Dalbanjan, AfraQuasar A. Nadaf, Arihant Jayawant Kadapure, et al.
Journal of the Indian Chemical Society (2025), pp. 101592-101592
Closed Access
Microbial-based natural products as potential inhibitors targeting DNA gyrase B of Mycobacterium tuberculosis: an in silico study
Tilal Elsaman, Magdi Awadalla Mohamed, Malik Suliman Mohamed, et al.
Frontiers in Chemistry (2025) Vol. 13
Open Access
In Silico Screening for Small Molecules to Alter Calpain Proteolysis Through Modulating Conformation Changes Induced by Heterodimerization
Pitambar Poudel, Іван Шаповалов, Shailesh Kumar Panday, et al.
(2025)
Closed Access
A Chronicle Review of In-Silico Approaches for Discovering Novel Antimicrobial Agents to Combat Antimicrobial Resistance
Nagarjuna Prakash Dalbanjan, S. K. Praveen Kumar
Indian Journal of Microbiology (2024) Vol. 64, Iss. 3, pp. 879-893
Closed Access | Times Cited: 5
Advances in structure-based drug design: The potential for precision therapeutics in psychiatric disorders
Dongmei Cao, Pei Zhang, Sheng Wang
Neuron (2024) Vol. 112, Iss. 4, pp. 526-538
Closed Access | Times Cited: 4
Evaluation of novel compounds as anti-bacterial or anti-virulence agents
Brankica Filipić, Dušan Ušjak, Martina Hrast Rambaher, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 4
AI-driven microbial medicine development
Komal Dharmani, Anjana Sinha, Navaneet Chaturvedi
Methods in microbiology (2024), pp. 101-124
Closed Access | Times Cited: 4
Catalytic resilience of multicomponent aromatic ring-hydroxylating dioxygenases in Pseudomonas for degradation of polycyclic aromatic hydrocarbons
Prerna J. Yesankar, Ayurshi Patil, Atya Kapley, et al.
World Journal of Microbiology and Biotechnology (2023) Vol. 39, Iss. 7
Closed Access | Times Cited: 13
Harvesting phosphorus-containing moieties for their antibacterial effects
Manuela Voráčová, Matej Zore, Jari Yli‐Kauhaluoma, et al.
Bioorganic & Medicinal Chemistry (2023) Vol. 96, pp. 117512-117512
Open Access | Times Cited: 13
In Silico Structural Modeling and Binding Site Analysis of Cerebroside Sulfotransferase (CST): A Therapeutic Target for Developing Substrate Reduction Therapy for Metachromatic Leukodystrophy
Nivedita Singh, Ajay Singh
ACS Omega (2024) Vol. 9, Iss. 9, pp. 10748-10768
Open Access | Times Cited: 3
Isomer-sourced structure iteration methods for in silico development of inhibitors: Inducing GTP-bound NRAS-Q61 oncogenic mutations to an “off-like” state
Zheyao Hu, Jordi Martı́
Computational and Structural Biotechnology Journal (2024) Vol. 23, pp. 2418-2428
Open Access | Times Cited: 3
Bombax ceiba extract and its metabolites as α-glucosidase inhibitors for diabetes
Mudassir Hassan, Azhar Rasul, Farhat Jabeen, et al.
Journal of King Saud University - Science (2024) Vol. 36, Iss. 8, pp. 103267-103267
Open Access | Times Cited: 3
High-throughput virtual screening of Streptomyces spp. metabolites as antiviral inhibitors against the Nipah virus matrix protein
Mark Andrian B. Macalalad, Nyzar Mabeth O. Odchimar, Fredmoore L. Orosco
Computational Biology and Chemistry (2024) Vol. 112, pp. 108133-108133
Closed Access | Times Cited: 3
Insights into the computer-aided drug design and discovery based on anthraquinone scaffold for cancer treatment: A protocol for systematic review
Hui Ming Chua, Said Moshawih, Hui Poh Goh, et al.
PLoS ONE (2023) Vol. 18, Iss. 9, pp. e0290948-e0290948
Open Access | Times Cited: 10
Amazon Plant‐Derived Compounds Suppressing Dengue NS5 Protein: Insights from Computational Drug Development and Network Pharmacology Approach
Nasim Ahmed, Muhammad Abdul Bari, Partha Biswas, et al.
ChemistrySelect (2024) Vol. 9, Iss. 10
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top